Lipoproteína (a), ¿es un factor de riesgo en la enfermedad aterotrombótica coronaria?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Revista Portuguesa De Pneumologia

• Publication date

  2001-09-01

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.

  2001cited by this paper
• High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms.

  2000cited by this paper
• Apolipoprotein(a) size polymorphism in young adults with ischemic stroke.

  1999cited by this paper
• Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

  1999cited by this paper
• Evidence that Modifications of Lp(a) In Vivo Inhibit Plasmin Formation on Fibrin

  1999cited by this paper
• Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.

  1998cited by this paper
• Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance

  1997cited by this paper
• Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.

  1996cited by this paper
• Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.

  1995cited by this paper
• Lipoprotéine(a), hypofibrinolyse et athérothrombose, quo vadis ?

  1995cited by this paper
• Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.

  1994cited by this paper
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

  1994cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.

  1994cited by this paper
• Apolipoproteins and ischaemic heart disease: implications for screening.

  1994cited by this paper
• Lp(a) lipoprotein in cardiovascular disease.

  1994cited by this paper
• Lp(a) lipoprotein: an overview.

  1994cited by this paper
• Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

  1994cited by this paper
• Hormonal agents used in lowering lipoprotein(a).

  1994cited by this paper
• Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.

  1993cited by this paper
• Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.

  1993cited by this paper
• Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.

  1993cited by this paper
• Relevance of Lipoprotein (a) in Cardiovascular Disease: Methodological Approaches

  1993cited by this paper
• Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.

  1992cited by this paper
• Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.

  1992cited by this paper
• Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.

  1992cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

  1991cited by this paper
• Expressed hypervariable polymorphism of apolipoprotein (a).

  1991cited by this paper
• Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.

  1991cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis.

  1990cited by this paper
• A potential basis for the thrombotic risks associated with lipoprotein(a)

  1989cited by this paper
• Plasma lipoproteins: teaching old dogmas new tricks.

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators.

  1986cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.

  1984cited by this paper
• Human plasma lipoprotein [a]. Structural properties.

  1983cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Lipoprotein(a) and lipid profile in Añú Ethnicity residents of the Sinamaica Lagoon, in the Páez district, Zulia State – Venezuela

  2011cites this paper
• Origen étnico y enfermedad cardiovascular

  2008cites this paper